Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mohammed Orloff

Concepts (237)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Genetic Predisposition to Disease
11
2025
525
1.160
 Why?
Germ-Line Mutation
9
2013
62
0.990
 Why?
Hamartoma Syndrome, Multiple
8
2012
16
0.990
 Why?
PTEN Phosphohydrolase
13
2015
55
0.970
 Why?
Barrett Esophagus
2
2019
30
0.940
 Why?
Esophageal Neoplasms
2
2019
113
0.850
 Why?
Adenocarcinoma
3
2019
403
0.780
 Why?
Haplotypes
3
2020
95
0.720
 Why?
Homozygote
3
2019
58
0.620
 Why?
Polymorphism, Single Nucleotide
9
2021
506
0.620
 Why?
Carcinoma, Non-Small-Cell Lung
1
2020
177
0.580
 Why?
Proto-Oncogene Proteins c-akt
4
2012
168
0.550
 Why?
Databases, Factual
1
2020
721
0.520
 Why?
Alleles
6
2021
279
0.420
 Why?
Lung Neoplasms
3
2020
643
0.410
 Why?
Phosphatidylinositol 3-Kinases
2
2012
147
0.390
 Why?
Genotype
6
2021
563
0.370
 Why?
Scavenger Receptors, Class A
1
2011
39
0.350
 Why?
Extracellular Matrix Proteins
1
2011
69
0.350
 Why?
Case-Control Studies
5
2025
1202
0.300
 Why?
Transcription Factors
1
2011
570
0.280
 Why?
Genetic Variation
3
2021
226
0.270
 Why?
Breast Neoplasms
7
2017
1203
0.270
 Why?
Heart Defects, Congenital
2
2025
615
0.270
 Why?
Humans
37
2025
52441
0.270
 Why?
Thyroid Neoplasms
4
2012
111
0.270
 Why?
Inositol
1
2025
18
0.240
 Why?
Limb Deformities, Congenital
1
2025
15
0.230
 Why?
Genes, Wilms Tumor
1
2005
1
0.230
 Why?
Population
1
2005
8
0.230
 Why?
Gene Frequency
3
2020
97
0.230
 Why?
Glomerulosclerosis, Focal Segmental
1
2005
17
0.230
 Why?
Genome
2
2019
61
0.220
 Why?
Capacity Building
1
2024
18
0.210
 Why?
Female
22
2025
28277
0.210
 Why?
Exome
2
2025
53
0.210
 Why?
Adult
16
2025
14205
0.200
 Why?
Linkage Disequilibrium
2
2020
41
0.200
 Why?
Middle Aged
16
2021
13133
0.200
 Why?
Smoke-Free Policy
1
2022
10
0.190
 Why?
Tobacco Smoke Pollution
1
2022
50
0.190
 Why?
Dietary Supplements
1
2025
470
0.180
 Why?
Inheritance Patterns
1
2021
22
0.170
 Why?
Phenotype
7
2021
792
0.170
 Why?
Models, Genetic
5
2013
173
0.170
 Why?
Risk Factors
5
2019
3971
0.170
 Why?
Succinate Dehydrogenase
2
2011
22
0.160
 Why?
Stilbenes
2
2010
58
0.160
 Why?
Male
15
2025
26874
0.160
 Why?
Fires
1
2020
15
0.160
 Why?
Aged
11
2020
10242
0.160
 Why?
Agriculture
1
2020
18
0.160
 Why?
Tobacco Products
1
2021
126
0.160
 Why?
Cluster Analysis
4
2013
236
0.150
 Why?
Social Media
1
2021
120
0.150
 Why?
Aged, 80 and over
5
2020
3449
0.150
 Why?
Genomics
1
2020
266
0.140
 Why?
Cell Proliferation
3
2010
1013
0.140
 Why?
Prostatic Neoplasms
2
2012
398
0.130
 Why?
Pulmonary Disease, Chronic Obstructive
1
2020
149
0.130
 Why?
Gene Expression Regulation, Neoplastic
3
2010
853
0.130
 Why?
Young Adult
8
2025
4346
0.130
 Why?
Prognosis
2
2020
2100
0.130
 Why?
Endometrial Neoplasms
2
2015
144
0.130
 Why?
Leprosy
1
2016
8
0.120
 Why?
Hypertension
1
2021
560
0.120
 Why?
Emergency Service, Hospital
1
2020
521
0.120
 Why?
Asthma
1
2020
313
0.120
 Why?
Microsatellite Repeats
2
2012
42
0.120
 Why?
Regression Analysis
2
2017
400
0.120
 Why?
Tuberculosis
1
2016
127
0.110
 Why?
Aromatase
1
2015
8
0.110
 Why?
Arkansas
4
2024
2013
0.110
 Why?
Genetic Linkage
2
2011
26
0.100
 Why?
Adolescent
8
2021
6713
0.100
 Why?
Sirolimus
2
2010
72
0.100
 Why?
Bone Morphogenetic Protein Receptors, Type I
1
2013
3
0.100
 Why?
Genome-Wide Association Study
2
2012
184
0.100
 Why?
Smad4 Protein
1
2013
6
0.100
 Why?
Genetic Testing
2
2010
130
0.100
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2012
17
0.100
 Why?
Cohort Studies
3
2012
1576
0.100
 Why?
Colonic Polyps
1
2013
39
0.100
 Why?
Receptors, Cell Surface
1
2013
111
0.090
 Why?
Mitochondrial Diseases
1
2012
44
0.090
 Why?
Codon, Nonsense
1
2012
28
0.090
 Why?
Flavin-Adenine Dinucleotide
1
2011
4
0.090
 Why?
Antigens, CD
1
2013
213
0.090
 Why?
NAD
1
2011
46
0.090
 Why?
Genes, p53
1
2011
50
0.090
 Why?
DNA, Neoplasm
1
2012
146
0.090
 Why?
Mutation, Missense
1
2012
108
0.090
 Why?
Siblings
1
2011
35
0.090
 Why?
Adenoma
1
2012
114
0.090
 Why?
Taxoids
1
2011
38
0.090
 Why?
Risk
1
2012
315
0.090
 Why?
Gene Expression Profiling
3
2012
1099
0.090
 Why?
Software
1
2013
281
0.080
 Why?
Intestinal Polyps
1
2010
7
0.080
 Why?
Receptors, Androgen
1
2010
48
0.080
 Why?
Colorectal Neoplasms
2
2012
286
0.080
 Why?
Cephalometry
1
2010
18
0.080
 Why?
Tumor Microenvironment
1
2012
257
0.080
 Why?
Gene Dosage
1
2009
73
0.080
 Why?
Head
1
2010
70
0.080
 Why?
Carcinoma, Transitional Cell
1
2010
54
0.080
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
141
0.080
 Why?
Patient Selection
1
2010
269
0.080
 Why?
Cell Communication
1
2009
74
0.080
 Why?
Age Factors
1
2012
1120
0.070
 Why?
Immunohistochemistry
1
2011
977
0.070
 Why?
Drug Resistance, Neoplasm
1
2011
336
0.070
 Why?
Urinary Bladder Neoplasms
1
2010
166
0.070
 Why?
Smoking
1
2012
514
0.070
 Why?
United States
3
2025
5215
0.070
 Why?
Chromosome Mapping
2
2021
149
0.070
 Why?
Prevalence
2
2021
1016
0.070
 Why?
Prospective Studies
4
2017
2433
0.070
 Why?
Mass Screening
1
2010
354
0.070
 Why?
Rural Population
2
2022
587
0.060
 Why?
Cell Line, Tumor
4
2011
1429
0.060
 Why?
Physical Chromosome Mapping
1
2005
7
0.060
 Why?
Antineoplastic Agents
2
2011
1216
0.060
 Why?
Frasier Syndrome
1
2005
1
0.060
 Why?
Denys-Drash Syndrome
1
2005
2
0.060
 Why?
DNA Copy Number Variations
1
2025
116
0.060
 Why?
Exons
1
2005
101
0.060
 Why?
Child
5
2020
7194
0.050
 Why?
Models, Theoretical
1
2005
181
0.050
 Why?
Gene Expression Regulation
1
2008
1004
0.050
 Why?
Mutation
2
2010
1331
0.050
 Why?
Logistic Models
1
2025
930
0.050
 Why?
Biopsy
1
2005
594
0.050
 Why?
Polyproteins
1
2022
3
0.050
 Why?
Child, Preschool
3
2020
4046
0.050
 Why?
RNA, Viral
1
2022
123
0.050
 Why?
Risk Assessment
2
2021
1349
0.050
 Why?
Phosphoproteins
1
2022
123
0.040
 Why?
Cardiomyopathy, Hypertrophic, Familial
1
2021
6
0.040
 Why?
United States Food and Drug Administration
1
2021
89
0.040
 Why?
Membrane Glycoproteins
1
2022
239
0.040
 Why?
Nutrition Surveys
1
2021
119
0.040
 Why?
Loss of Heterozygosity
2
2012
78
0.040
 Why?
Stromal Cells
2
2012
76
0.040
 Why?
Nicotine
1
2021
174
0.040
 Why?
TOR Serine-Threonine Kinases
2
2010
83
0.040
 Why?
Self Report
1
2021
221
0.040
 Why?
Pedigree
2
2010
126
0.040
 Why?
Seasons
1
2020
95
0.040
 Why?
Signal Transduction
3
2010
1724
0.040
 Why?
Odds Ratio
1
2021
563
0.040
 Why?
Neoplasms
1
2009
1314
0.040
 Why?
Air Pollution
1
2020
51
0.040
 Why?
Phosphorylation
2
2010
536
0.040
 Why?
Gene Expression
2
2012
618
0.040
 Why?
Sensitivity and Specificity
2
2012
871
0.040
 Why?
Predictive Value of Tests
2
2012
938
0.040
 Why?
Pregnancy
1
2025
2642
0.040
 Why?
Infant, Newborn
1
2025
2871
0.040
 Why?
Infant
2
2020
3709
0.030
 Why?
Dose-Response Relationship, Drug
2
2010
1365
0.030
 Why?
Angiopoietin-2
1
2017
14
0.030
 Why?
Angiopoietin-1
1
2017
16
0.030
 Why?
Receptor, TIE-2
1
2017
16
0.030
 Why?
Fibroblast Growth Factor 2
1
2017
35
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
48
0.030
 Why?
Matrix Metalloproteinase 9
1
2017
88
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
186
0.030
 Why?
Cross-Sectional Studies
1
2021
1677
0.030
 Why?
Neovascularization, Pathologic
1
2017
158
0.030
 Why?
Neoadjuvant Therapy
1
2017
124
0.030
 Why?
HapMap Project
1
2015
3
0.030
 Why?
Introns
1
2015
53
0.030
 Why?
Pilot Projects
1
2016
725
0.030
 Why?
Peutz-Jeghers Syndrome
1
2013
2
0.030
 Why?
Databases, Genetic
1
2013
82
0.020
 Why?
Genome, Human
1
2013
121
0.020
 Why?
Validation Studies as Topic
1
2012
10
0.020
 Why?
Penetrance
1
2012
7
0.020
 Why?
Neoplasm Grading
1
2012
127
0.020
 Why?
Genetic Association Studies
1
2012
124
0.020
 Why?
Vincristine
1
2011
89
0.020
 Why?
Anthracyclines
1
2011
34
0.020
 Why?
Inhibitory Concentration 50
1
2010
74
0.020
 Why?
Formazans
1
2010
2
0.020
 Why?
Tetrazolium Salts
1
2010
13
0.020
 Why?
Immunoblotting
1
2010
118
0.020
 Why?
Paclitaxel
1
2011
91
0.020
 Why?
Androgen Antagonists
1
2010
12
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.020
 Why?
Drug Synergism
1
2010
147
0.020
 Why?
HEK293 Cells
1
2011
236
0.020
 Why?
Mitogen-Activated Protein Kinases
1
2010
152
0.020
 Why?
Epithelial Cells
1
2012
217
0.020
 Why?
Michigan
1
2010
26
0.020
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2010
16
0.020
 Why?
Point Mutation
1
2010
70
0.020
 Why?
Neoplasm Transplantation
1
2010
86
0.020
 Why?
Kidney Neoplasms
1
2012
181
0.020
 Why?
Androgens
1
2010
70
0.020
 Why?
Transplantation, Heterologous
1
2010
78
0.020
 Why?
Heredity
1
2009
2
0.020
 Why?
BRCA2 Protein
1
2009
18
0.020
 Why?
Adenosine Triphosphate
1
2011
234
0.020
 Why?
Endoscopy, Gastrointestinal
1
2010
73
0.020
 Why?
Comparative Genomic Hybridization
1
2009
37
0.020
 Why?
Polymerase Chain Reaction
1
2011
458
0.020
 Why?
Mice, Nude
1
2010
230
0.020
 Why?
Proteins
1
2012
353
0.020
 Why?
BRCA1 Protein
1
2009
35
0.020
 Why?
Chi-Square Distribution
1
2010
292
0.020
 Why?
Cell Cycle
1
2010
236
0.020
 Why?
Protein Binding
1
2011
673
0.020
 Why?
Diagnosis, Differential
1
2012
1028
0.020
 Why?
Gene Deletion
1
2010
279
0.020
 Why?
Algorithms
1
2013
673
0.020
 Why?
Cell Survival
1
2010
598
0.020
 Why?
Neoplastic Stem Cells
1
2009
88
0.020
 Why?
Promoter Regions, Genetic
1
2010
465
0.020
 Why?
Neoplasm Invasiveness
1
2009
278
0.020
 Why?
Incidence
1
2012
1096
0.020
 Why?
Neoplasm Staging
1
2011
768
0.020
 Why?
Microscopy, Confocal
1
2008
75
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2009
412
0.020
 Why?
Cell Transformation, Neoplastic
1
2009
187
0.020
 Why?
Membrane Proteins
1
2010
344
0.020
 Why?
Cell Differentiation
1
2011
667
0.020
 Why?
Chromosome Aberrations
1
2009
295
0.020
 Why?
Survival Rate
1
2010
944
0.020
 Why?
Registries
1
2010
638
0.020
 Why?
Treatment Outcome
1
2017
5508
0.020
 Why?
Chromosomes, Human
1
2005
41
0.010
 Why?
DNA Methylation
1
2009
573
0.010
 Why?
Time Factors
1
2010
2987
0.010
 Why?
Reproducibility of Results
1
2005
1223
0.010
 Why?
Mice
1
2010
5899
0.010
 Why?
Animals
1
2010
13485
0.010
 Why?
Orloff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (237) concept(s)
_
Co-Authors Expand Description
See all (26) people
_
Similar People Expand Description
See all (27) people
_
Same Department Expand Description
Search Department